Author

SungHwan Kim 1

1 Celltrion, Incheon, Korea, Republic Of

CROSS-IMMUNOGENICITY: ANTIBODIES TO INFLIXIMAB IN REMICADE-TREATED IBD PATIENTS SIMILARLY RECOGNIZE THE BIO-SIMILAR REMSIMA

Shomron Ben-Horin, Miri Yavzori, Orit Picard, SooYoung Lee, SungHwan Kim, Yehuda Chowers

Item 1 - 1 / 1
1